Clinical and Translational Medicine (Nov 2021)

Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells

  • Jiale Wu,
  • Yuntong Li,
  • Jiaqi Wu,
  • Huaxin Song,
  • Yigang Tang,
  • Ni Yan,
  • Lili Wu,
  • Sujiang Zhang,
  • ChunKang Chang,
  • Min Lu

DOI
https://doi.org/10.1002/ctm2.593
Journal volume & issue
Vol. 11, no. 11
pp. n/a – n/a

Abstract

Read online

No abstracts available.